represents the number of DEGs included in the cluster; the bottom left corner shows the p-value of the profile. X and Y-axes represent time points and relative gene expression levels, respectively. (B) The interaction network of significant terms enriched with DEGs from Cluster 3. Functional annotation was performed in ClueGO by using Gene Ontology (biological processes), KEGG, REACTOME and Wikipathways. The functionally grouped network is linked based on the kappa score of terms. The size and color of a node represents the term's significance and its attachment to revealed groups. Only pathways with p < 0.05 after Bonferroni step down correction for multiple testing were included in the networks. Ursolic acid HeLa ↓cell viability (IC 50 = 9.54 ± 0.98 µM), ↑PS externalization, ↑activity of caspases-9, -3, ↑cytochrome c release, ↑Bax, ↑Bak, ↓Bcl-2, ↓Bcl-xL, ↓p-p38, ↓p-ERK1/2, ↑DUSP 1, 2, 4, 5, 6, 7, 9, 10 ERK1/2 (U0126 pretreatment → ↓effect of ursolic acid on Bax/Bcl-2, cytochrome c release, cleavage of caspase-3)
[15]
Ursolic acid + cisplatin H8, HeLa, SiHa, C-33A, ME-180 ↓cell growth, apoptosis, ↓Bcl-2, ↓NF-kB p65, ↓NF-kB p65 nuclear translocation, ↑Bax, ↑cleaved caspase-3 and PARP -
Ursolic acid into poly (DL-lactideco0glycolide) nanoparticles
CaSki, HeLa, C4-1, SiHa ↓cell growth, ↓colony formation, ↓cell migration, ↑PS externalization, ↑cleaved caspases-8, -9, -3, ↑p53, ↑Bax/ Bcl-2, ↑Fas, ↓cIAP-1; ↓SiHa, CaSki and HeLa xenograft growth, ↑p53, ↓Bcl-2, ↑survival rate
